cropper
update
National Cannabis Newswire
update
  • Home
  • Categories
    • news
    • trends
    • insights
    • industry
    • legalization
    • health
    • culture
    • advocacy
    • Brands
    • New Mexico Dispensaries
    • Arizona Dispensaries
February 06.2026
2 Minutes Read

How The $28.5 Million Sale of Ohio Cannabis Facility Reflects Industry Growth

Former Ayr cannabis cultivation facility in Ohio sells for $28.5 million

Ohio Cannabis Cultivation Facility Change Ownership for $28.5 Million

The cannabis industry is witnessing rapid growth, particularly in states that have embraced recreational marijuana. A striking example is the recent sale of a cannabis cultivation facility in Parma, Ohio, which fetched an impressive $28.5 million. This indoor grow site, with a sprawling 58,604 square feet on 3.4 acres, was sold to Parma Propco, LLC, a limited liability company linked to New York-based Power REIT. Previously owned by Ayr Wellness and acquired via its 2022 purchase of Greenlight Management, this facility is set to continue operating under Ayr's management.

Sector Market Trends Reflect Growth in Sales

The sale comes as Ohio's cannabis market thrives. Data from the Ohio Department of Commerce reveals that 2025 marked a significant year, with more than $836 million generated from nonmedical cannabis sales. When combined with the $233 million in medical cannabis sales, the total soared to over $1 billion, indicating a robust demand that has caught the eye of investors and REITs looking to expand their presence in this burgeoning market.

Implications for Ayr Wellness and the Cannabis Industry

Ayr Wellness, which still operates the Parma facility, is on a path of financial restructuring, having already reduced its debt by 50%, a crucial move for long-term sustainability. Following a recent corporate restructuring that hints at eventual liquidation, the company remains focused on growth, as evidenced by the launching of a new adult-use dispensary in Parma in November 2025. This dual strategy of cultivation and retail aligns with the overall trend in the cannabis market where vertical integration is proving to be beneficial.

Understanding the Shift in Cannabis Operations

While the sale of the Parma property is notable, it also reflects broader trends in the cannabis industry where larger players are consolidating resources. With investors like Power REIT acquiring these properties, it raises questions about the future of cannabis cultivation and distribution in the state. Will Ayr continue to lease the property to maintain its operations, or will Power REIT pivot to utilize the facility for different ventures?

Decisions That May Shape the Future of Cannabis

As the cannabis market evolves, investors and businesses must consider the impacts of state regulations and market trends. As consumers embrace legal marijuana, business moves like the sale of this facility signal investment confidence. Companies need to ask critical questions: How will they navigate the regulatory environment? What strategic partnerships might position them for success in an increasingly competitive landscape?

The $28.5 million sale of the former Ayr cannabis cultivation facility in Ohio is more than a transaction; it is a reflection of the growing confidence in the cannabis market and its future direction. As more states lean toward legalization, industry stakeholders must stay informed and adapt to shifts in both consumer demand and regulatory frameworks.

Understanding these dynamics is crucial for anyone involved in the cannabis industry. For more insights on the evolving landscape, visit our blog for the latest news and analysis.

news

28 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts

Texas Revokes Cresco Labs' Cannabis Permit: What Does This Mean for the Industry?

Update Texas’s Medical Marijuana Market Takes a Surprising Turn In a recent turn of events that has left many in the cannabis industry scratching their heads, Texas officials have revoked three conditional permits intended for the expanded medical marijuana program. This move specifically affects multistate operator (MSO) Cresco Labs among others, leading to questions surrounding the integrity and transparency of the state’s licensing processes. Understanding the Revocation of Cresco Labs’ Permit The Texas Department of Public Safety (DPS) announced that it identified a “tabulation error” in the scoring of applications for the Texas Compassionate Use Program (TCUP). As a consequence, Cresco Labs, which initially appeared to have received permission, now finds itself in a position of uncertainty. The department's brief statement pointed out that only the methodology for score calculation was adjusted, sparking concerns about how decisions are being made behind closed doors. Who Benefits from the Rescinded Permits? Following the correction, the state awarded conditional permits to Bayou City Medical Dispensary and two other companies. This realignment raises questions about operational readiness and the criteria used for selection in a market that has shown significant growth. In 2025, the number of registered medical cannabis patients in Texas hit 135,470—an increase of almost 32% year over year. This notable surge indicates a strong demand for medical cannabis, and replacing Cresco with a local entity seems to align with Texas's push for regional involvement, enhancing local business opportunities. The Broader Implications for the Cannabis Industry This revocation highlights growing pains in the legal cannabis industry as it expands across the U.S. With stricter regulations and a focus on patient-first policies, Texas's decision is emblematic of how state markets are still finding their footing in balancing local interests with national operators like Cresco Labs, known for its commitment to establishing patient-centric programs. The stakes are high as large MSOs continue to view Texas as a lucrative market despite current roadblocks. What’s Next for Cresco Labs? Cresco Labs has declared its intention to evaluate its options following this unexpected revocation. Their confidence remains in the original award of the permit, and as the company navigates this setback, it underscores a critical sentiment prevalent in the cannabis industry—persistence is key. Cresco's CEO Charlie Bachtell emphasized their ongoing commitment to building what they describe as patient-first medical cannabis programs in highly regulated markets. The Future of Texas’s Medical Cannabis Market With new permits awarded, the ultimate question remains: how will newly permitted companies meet operational benchmarks within two years? They must demonstrate their readiness to serve the increasing number of patients seeking access to medical cannabis. As the landscape continues to shift, Texas may become a model for other states grappling with robust regulatory frameworks and market expansions as more operators vie for consumer attention. This move is just another chapter in the evolving saga of cannabis regulation in Texas and the broader United States. For bloggers and industry enthusiasts keeping tabs on these developments, it’s critical to analyze how state-level decisions influence operational dynamics and patient access.

Does Federal Marijuana Rescheduling Transform Cannabis Advertising Rules?

Update What Federal Marijuana Rescheduling Means for Cannabis Advertising The recent federal rescheduling of marijuana is stirring conversation within the cannabis industry, particularly regarding its impact on advertising regulations. While the change may present opportunities for enhanced marketing strategies, experts warn that it won't lead to a wholesale lifting of restrictions that cannabis companies face on major advertising platforms. Understanding the Current Landscape of Cannabis Advertising As it stands, advertising cannabis remains a challenging endeavor. Major technology platforms, including Google and Instagram, continue to enforce strict advertising rules that prohibit companies from showcasing cannabis products or promoting deals. This is the case even in markets like Canada, where adult-use cannabis is fully legal. Dan Serard, the founder of Boston-based digital marketing agency Cannabis Creative Group, emphasizes that platforms are currently not making adjustments but are open to discussions depending on the future legalization trajectory. The Impact of Section 280E Tax Relief One of the most pressing issues for cannabis operators has been the restrictive tax implications under Section 280E of the Internal Revenue Code. This regulation forces cannabis businesses to pay federal taxes on gross income without deductions for regular business expenses, often leading to tax rates above 70%. With the rescheduling potentially alleviating some financial strain, many believe this newfound cash flow could provide cannabis operators the ability to invest in marketing efforts, thereby enhancing brand visibility and community engagement. The Slow Shift in Advertising Policies Despite the federal rescheduling, industry insiders believe significant changes to advertising norms will not happen overnight. Marketing executives expect a gradual evolution where more medical operators can increase their marketing budgets, fuel public education efforts, and enhance search visibility. “What the cannabis industry should know,” Serard notes, “is that they’re positioning themselves for when this happens and are supportive of allowing for advertising when it does.” Forward-Looking Predictions for Cannabis Marketing Looking ahead, the upcoming hearings scheduled for June 29 aim to evaluate broader changes regarding cannabis under federal law. Marketing professionals are cautiously optimistic, suggesting that relief from 280E taxes could pave the way for strategies akin to those seen in the sports betting sector post-PASPA, where marketing became ubiquitous after the regulation changed. Engaging the Cannabis Community As cannabis companies brace for an uncertain yet potentially transformative period, community engagement will remain vital. Building trust through education and local outreach initiatives will not only position businesses favorably but also foster a supportive environment that encourages shifts in advertising regulations. Conclusion: Navigating the Evolving Landscape For cannabis industry stakeholders, navigating the evolving landscape requires resilience and foresight. As discussions surrounding advertising regulations progress, companies must continue to take a cautious approach but remain hopeful for increased opportunities to connect with consumers. By prioritizing community engagement and advocating for legislative changes, businesses can prepare for what’s to come within the cannabis advertising space.

Unlocking the Benefits of Medical Marijuana for Seniors: A New Era in Cannabis Care

Update Understanding the Historical Context of Cannabis ReschedulingThe rescheduling of cannabis from Schedule I to Schedule III marked a watershed moment, particularly for older Americans. For over 50 years, cannabis was seen as one of the most dangerous drugs with no accepted medical use. However, the recent changes challenge that narrative, opening the door for medical marijuana to play a crucial role in senior healthcare. By correcting its classification, the government has initiated a necessary dialogue about the benefits that cannabis can provide, especially for older individuals suffering from chronic pain, anxiety, and other health issues.The Human Stories Behind the Medical Marijuana MovementOne major reason for the push towards medical marijuana is the demographic shift occurring within the United States. By 2050, nearly a quarter of the population will be over 65 years old, a statistic that is driving interest in medical cannabis. Consumers like Howard Kessler from the Commonwealth Project have been vocal proponents, appealing directly to decision-makers to push this initiative forward. With testimonials from seniors finding relief in cannabis-based products, this movement is more than just policy; it is deeply personal and heartfelt.The Challenges of Implementation in Senior CareWhile the rescheduling of medical marijuana is celebrated, it also brings to light severe inadequacies in the current infrastructure to support this burgeoning sector. As Emily Dufton points out, the absence of a coherent legal and regulatory framework could lead to confusion and backlash. Will healthcare providers feel adequately prepared to recommend cannabis? Will dispensaries be able to meet a surge in demand among seniors? These questions highlight the complexities of implementing such significant policy changes.What This Means for the Future of the Cannabis IndustryThe potential for medical marijuana to penetrate the senior market signifies a new era for the cannabis industry. Emerging regulations may not only expand the variety of products available to seniors but also reshape the existing market. Experts estimate that incorporating products like CBD into Medicare coverage could create a revenue boom for the cannabis industry while positively impacting seniors' quality of life and pain management. As more seniors turn to cannabis, craft companies tuned into this demographic will thrive, creating new jobs and business opportunities.Call to Action: Advocate for Awareness and EducationIt is essential for community advocates, particularly those who focus on health and aging, to push for comprehensive educational campaigns around cannabis use. Older adults must feel informed and comfortable discussing cannabis options with their healthcare providers. By fostering informed discussions and providing easily understandable resources, we can help eliminate stigmas around cannabis use in older populations and ensure that they have safe access to potentially life-changing products.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*